Developmental medicine and child neurologyEditorial
undefined
Dec
2024
DMCN 2024 highlights: Quality research, epidemiology, and parental perspective.
No abstract available
References:
Katangwe TJ, Kruger M, Chimowa T, Maposa I, Van Toorn R, Solomons R, et al. Variables included in cerebral palsy registries globally: A scoping review. Dev Med Child Neurol. 2024; 66: 1148–56.
Romeo DM, Velli C, Sini F, Pede E, Cicala G, Cowan FM, et al. Neurological assessment tool for screening infants during the first year after birth: The Brief‐Hammersmith Infant Neurological Examination. Dev Med Child Neurol. 2024; 66: 1173–80.
Fehlings D, Makino A, Church P, Banihani R, Thomas K, Luther M, et al. The Hammersmith Infant Neurological Exam Scoring Aid supports early detection for infants wiht high probability of cerebral palsy. Dev Med Child Neurol. 2024; 66: 1255–7.
Forsyth R, Whyte J. Defining paediatric neurorehabilitation: You cannot improve what you cannot characterize. Dev Med Child Neurol. 2024; 66: 1123–32.
Ames SG, Delaney RK, Delgado‐Corcoran C, Houtrow AJ, Alvey J, Watt MH, et al. Impact of disability‐based discrimination in healthcare on parents of children with medical complexity. Dev Med Child Neurol. 2024; 66: 1226–33.